Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Experimental & Clinical Cancer Research
Published in: Journal of Experimental & Clinical Cancer Research 1/2017

Open Access 01-12-2017 | Erratum

Erratum to: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase

Authors: Franco Di Filippo, Simona Di Filippo, Anna Maria Ferrari, Raffaele Antonetti, Alessandro Battaglia, Francesca Becherini, Laia Bernet, Renzo Boldorini, Catherine Bouteille, Simonetta Buglioni, Paolo Burelli, Rafael Cano, Vincenzo Canzonieri, Pierluigi Chiodera, Alfredo Cirilli, Luigi Coppola, Stefano Drago, Luca Di Tommaso, Privato Fenaroli, Roberto Franchini, Andrea Gianatti, Diana Giannarelli, Carmela Giardina, Florence Godey, Massimo M. Grassi, Giuseppe B. Grassi, Siobhan Laws, Samuele Massarut, Giuseppe Naccarato, Maria Iole Natalicchio, Sergio Orefice, Fabrizio Palmieri, Tiziana Perin, Manuela Roncella, Massimo G. Roncalli, Antonio Rulli, Angelo Sidoni, Corrado Tinterri, Maria C. Truglia, Isabella Sperduti

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2017

Login to get access

Excerpt

Upon publication of the original article [1], it was noticed that the affiliation of the authors Vincenzo Canzonieri, Tiziana Perin and Samuele Massarut, “Centro di Riferimento Oncologico NCI IRCCS - Aviano” was incorrectly given as “Centro Regionale Oncologico”. This has now been acknowledged and corrected in this erratum. …
Literature
1.
Di Filippo F, Di Filippo S, Ferrari AM, Antonetti R, Battaglia A, Becherini F, Bernet L, Boldorini R, Bouteille C, Buglioni S, Burelli P. Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase. J Exp Clin Cancer Res. 2016;35(1):193.CrossRefPubMedPubMedCentral
Metadata
Title
Erratum to: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase
Authors
Franco Di Filippo
Simona Di Filippo
Anna Maria Ferrari
Raffaele Antonetti
Alessandro Battaglia
Francesca Becherini
Laia Bernet
Renzo Boldorini
Catherine Bouteille
Simonetta Buglioni
Paolo Burelli
Rafael Cano
Vincenzo Canzonieri
Pierluigi Chiodera
Alfredo Cirilli
Luigi Coppola
Stefano Drago
Luca Di Tommaso
Privato Fenaroli
Roberto Franchini
Andrea Gianatti
Diana Giannarelli
Carmela Giardina
Florence Godey
Massimo M. Grassi
Giuseppe B. Grassi
Siobhan Laws
Samuele Massarut
Giuseppe Naccarato
Maria Iole Natalicchio
Sergio Orefice
Fabrizio Palmieri
Tiziana Perin
Manuela Roncella
Massimo G. Roncalli
Antonio Rulli
Angelo Sidoni
Corrado Tinterri
Maria C. Truglia
Isabella Sperduti
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2017
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/s13046-017-0540-2

Other articles of this Issue 1/2017

Journal of Experimental & Clinical Cancer Research 1/2017 Go to the issue

Research

Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer

Research

Intake of Boron, Cadmium, and Molybdenum enhances rat thyroid cell transformation

Erratum

Erratum to: Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers

Research

Ternary cocktail nanoparticles for sequential chemo-photodynamic therapy

Research

Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

Research

Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits